Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Adenoviridae Infections

• Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant Melanoma
• Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation
• Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder Cancer
• Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab and Pegylated Liposomal Doxorubicin as Treatment for Ovarian Cancer.
• Posoleucel (ALVR105) for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standard of Care Following Allogeneic Hematopoietic Cell Transplantation
• An Exploratory Trial to Evaluate Efficacy and Safety for Combination Treatment of Adenovirus Double Suicide Gene Therapy
• A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection
• Radiofrequency Ablation Combined With Recombinant Human Adenovirus Type 5 in the Treatment of Hepatocellular Carcinoma.
• Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia
• The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation
• Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection
• Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
• A Multicenter Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection to Serve as Matched Historical Controls for Study CMX001-304
• Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors
• Study to Assess the Safety and Efficacy of Brincidofovir in Treatment of Early Versus Late Adenovirus Infection
• Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL)
• Safety Study of Adenovirus Hepatocyte Growth Factor to Treat Ischemic Heart Disease
• Cytotoxic T Cells to Prevent Virus Infections
• TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma
• Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus
• A Placebo Controlled Comparison of Topical Zirgan Versus Genteal Gel for the Treatment of Adenovirus Conjunctivitis
• Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
• Ganciclovir 0,15% Ophthalmic Gel in the Treatment of Adenovirus Keratoconjuntivitis
• Phase 2 Study to Evaluate Brincidofovir for the Prevention of Adenovirus Disease
• Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children